AVITA Medical, Inc. (RCEL) Non-Current Deffered Revenue (2019 - 2026)

AVITA Medical (RCEL) has reported Non-Current Deffered Revenue for 8 consecutive years, with $273000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Deffered Revenue fell 11.07% year-over-year to $273000.0; the trailing twelve-month figure through Jun 2026 stood at $273000.0 (down 11.07% YoY), and the FY2025 full-year result was $290000.0, down 10.49% from the prior year.
• Non-Current Deffered Revenue declined to $273000.0 in Q2 2026 per RCEL's latest filing, from $290000.0 in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $882000.0 in Q1 2022 and bottomed at $273000.0 in Q2 2026.
• Historically, Non-Current Deffered Revenue has averaged $437588.2 across 5 years, with a median of $349000.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Non-Current Deffered Revenue plunged 56.69% in 2023, then slipped 8.64% in 2024.
• Over 5 years, Non-Current Deffered Revenue stood at $698000.0 in 2022, then slumped by 48.85% to $357000.0 in 2023, then declined by 9.24% to $324000.0 in 2024, then fell by 10.49% to $290000.0 in 2025, then retreated by 5.86% to $273000.0 in 2026.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $273000.0, $290000.0, and $298000.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.